These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2752497)

  • 1. Targeted and sustained delivery of aclarubicin to lymphatics by lactic acid-oligomer microsphere in rat.
    Yoshikawa H; Nakao Y; Takada K; Muranishi S; Wada R; Tabata Y; Hyon SH; Ikada Y
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):802-4. PubMed ID: 2752497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective distribution of aclarubicin to regional lymph nodes with a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Matsumoto S; Muranishi S
    Anticancer Drugs; 1991 Jun; 2(3):261-6. PubMed ID: 1802020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer--a pilot study.
    Hagiwara A; Takahashi T; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Imanishi T; Yamasaki J; Takemoto Y; Kageyama N
    Anticancer Drugs; 1997 Aug; 8(7):666-70. PubMed ID: 9311442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adsorption and desorption of aclarubicin into and from activated carbon particles as drug carrier--an in vitro study].
    Matsumoto S; Iwamoto A; Yoneyama C; Hagiwara A; Takahashi T; Yoshikawa H; Muranishi S
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):227-31. PubMed ID: 1992916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visualising lymph nodes by aclarubicin bound to activated carbon particles in breast cancer surgery].
    Imanishi T; Hagiwara A; Sawai K; Yamaguchi T; Sakakura C; Shirasu M; Ohgaki M; Yamasaki J; Togawa T; Takahashi T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1796-8. PubMed ID: 9382535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride.
    Ichihara T; Sakamoto K; Mori K; Akagi M
    Cancer Res; 1989 Aug; 49(15):4357-62. PubMed ID: 2472878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trial of a treatment for lymph node metastases in patients with breast cancer using aclarubicin bound to activated carbon particles].
    Imanishi T; Sakakibara T; Yamazaki J; Ohyama T; Shirasu M; Tsujimoto H; Ohgaki M; Shimotsuma M; Hagiwara A; Sawai K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1635-7. PubMed ID: 7574780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of selective drug accumulation and retention in normal and regenerating liver by the use of lipiodol in portal venous infusion in rats].
    Suzuki H; Miyazaki M; Iinuma K; Udagawa I; Koshikawa H; Ito H; Okui K
    Nihon Geka Gakkai Zasshi; 1991 Oct; 92(10):1480-5. PubMed ID: 1660095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acid oligomer microspheres containing hydrophilic drugs.
    Wada R; Hyon SH; Ikada Y
    J Pharm Sci; 1990 Oct; 79(10):919-24. PubMed ID: 2280363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Ito M; Shobayashi S; Sasaki S; Ozaki K; Shirasu M
    Anticancer Drugs; 1992 Jun; 3(3):233-6. PubMed ID: 1525403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cytotoxic effect of a low density lipoprotein delivered aclarubicin on leukemia cells].
    Li W; Xi S; Zhang M
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):636-8. PubMed ID: 16200711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.
    Feng C; Li X; Dong C; Zhang X; Zhang X; Gao Y
    Drug Des Devel Ther; 2015; 9():4613-20. PubMed ID: 26316700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extended radical mastectomy using preoperative local injection of activated carbon particle adsorbing aclarubicin (ACR-CH)].
    Asaga T; Kobayashi O; Masuzawa C; Motohashi H; Okamoto T
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):313-9. PubMed ID: 2359386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron-loaded biodegradable microspheres as a nasal sustained delivery system: in vitro/in vivo studies.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Pharm Dev Technol; 2010 Jun; 15(3):258-65. PubMed ID: 22716466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles].
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Shimotsuma M; Shobayashi S; Ozaki K; Sasaki S; Tsujimoto H; Shirasu M
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1560-3. PubMed ID: 1530308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of oral aclarubicin treatment for tumors of the gastrointestinal track.
    Kagawa D; Nakamura T; Ueda T; Domae N; Uchino H
    Anticancer Res; 1993; 13(4):909-13. PubMed ID: 8352559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
    Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
    J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.